Bortezomib-Based Graft-Versus-Host Disease Prophylaxis in HLA-Mismatched Unrelated Donor Transplantation

PURPOSE: HLA-mismatched unrelated donor (MMUD) hematopoietic stem-cell transplantation (HSCT) is associated with increased graft-versus-host disease (GVHD) and impaired survival. In reduced-intensity conditioning (RIC), neither ex vivo nor in vivo T-cell depletion (eg, antithymocyte globulin) convin...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Koreth, John, Stevenson, Kristen E., Kim, Haesook T., McDonough, Sean M., Bindra, Bhavjot, Armand, Philippe, Ho, Vincent T., Cutler, Corey, Blazar, Bruce R., Antin, Joseph H., Soiffer, Robert J., Ritz, Jerome, Alyea, Edwin P.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2012
Assuntos:
Original Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3434979/
https://ncbi.nlm.nih.gov/pubmed/22869883
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2012.42.0984
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados